Cargando…

CYP26A1 Is a Novel Cancer Biomarker of Pancreatic Carcinoma: Evidence from Integration Analysis and In Vitro Experiments

BACKGROUND: CYP26A1 has been reported in multiple cancers. However, the role of CYP26A1 in pancreatic cancer (PC) has not been explored. METHOD: The public data used for this study was obtained from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and Cancer Cell Line Encyclopedia (CCL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yi, Wang, Yunxing, Zou, Yufeng, Yu, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192288/ https://www.ncbi.nlm.nih.gov/pubmed/35707714 http://dx.doi.org/10.1155/2022/5286820

Ejemplares similares

CYP26A1 Is a Novel Biomarker for Betel Quid-Related Oral and Pharyngeal Cancers
por: Chen, Ping-Ho, et al.
Publicado: (2020)

Cyp26 Enzymes Facilitate Second Heart Field Progenitor Addition and Maintenance of Ventricular Integrity
por: Rydeen, Ariel B., et al.
Publicado: (2016)

CYP26B1-related disorder: expanding the ends of the spectrum through clinical and molecular evidence
por: Silveira, Karina C., et al.
Publicado: (2023)

Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome
por: Li, Dan, et al.
Publicado: (2021)

Association Study between Novel CYP26 Polymorphisms and the Risk of Betel Quid-Related Malignant Oral Disorders
por: Wu, Shyh-Jong, et al.
Publicado: (2015)

Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo
por: Armstrong, J L, et al.
Publicado: (2007)

Nonsyndromic bilateral and unilateral optic nerve aplasia: first familial occurrence and potential implication of CYP26A1 and CYP26C1 genes
por: Meire, Françoise, et al.
Publicado: (2011)

Exploring novel biomarkers in dilated cardiomyopathy‑induced heart failure by integrated analysis and in vitro experiments
por: Zhou, Lei, et al.
Publicado: (2023)

Prognostic Analysis and Biomarkers Identification of Immune Infiltration in Early and Late Stage Hepatocellular Carcinoma Based on TCGA Data
por: Jiang, Wenying, et al.
Publicado: (2023)

Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma
por: Li, Hongzhe, et al.
Publicado: (2017)

CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors
por: Yan, Liang, et al.
Publicado: (2020)

Integration analysis identifies MYBL1 as a novel immunotherapy biomarker affecting the immune microenvironment in clear cell renal cell carcinoma: Evidence based on machine learning and experiments
por: Wang, Tengda, et al.
Publicado: (2022)

CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma
por: Zou, Xiong, et al.
Publicado: (2021)

Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8(+) T cells
por: He, Weizhi, et al.
Publicado: (2023)

Sonic Hedgehog Signaling Is Required for Cyp26 Expression during Embryonic Development
por: El Shahawy, Maha, et al.
Publicado: (2019)

New luciferin-based probe substrates for human CYP26A1
por: Sharma, Shishir, et al.
Publicado: (2020)

In vitro and In silico studies of interactions of cathinone with human recombinant cytochrome P450 CYP(1A2), CYP2A6, CYP2B6, CYP2C8, CYP2C19, CYP2E1, CYP2J2, and CYP3A5
por: Lim, Sharoen Yu Ming, et al.
Publicado: (2022)

Initiation of cyp26a1 Expression in the Zebrafish Anterior Neural Plate by a Novel Cis-Acting Element
por: Chen, Chunhong, et al.
Publicado: (2016)

Role of TFRC as a Novel Prognostic Biomarker and in Immunotherapy for Pancreatic Carcinoma
por: Yang, Cheng, et al.
Publicado: (2022)

CCL22 and CCL26 are potential biomarkers for predicting distant metastasis in thyroid carcinoma
por: Tong, Junyu, et al.
Publicado: (2022)

Profiling and Integrated Analysis of Differentially Expressed MicroRNAs as Novel Biomarkers of Hepatocellular Carcinoma
por: Xie, Yuwei, et al.
Publicado: (2022)

Regulation of cyp26a1 on Th17 cells in mouse peri-implantation
por: Liu, Hai-Yan, et al.
Publicado: (2014)

Regulating Retinoic Acid Availability during Development and Regeneration: The Role of the CYP26 Enzymes
por: Roberts, Catherine
Publicado: (2020)

Cyp26a1 supports postnatal retinoic acid homeostasis and glucoregulatory control
por: Yoo, Hong Sik, et al.
Publicado: (2023)

Bioinformatic evidences and analysis of putative biomarkers in pancreatic ductal adenocarcinoma
por: Gu, Yuan, et al.
Publicado: (2019)

Radioactive (125)I seed implantation for pancreatic cancer with unexpected liver metastasis: A preliminary experience with 26 patients
por: Li, Cheng-Gang, et al.
Publicado: (2021)

Experiment 26
por: CERN PhotoLab
Publicado: (1967)

Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers
por: Follia, Laura, et al.
Publicado: (2019)

CYP1B1-AS1 Is a Novel Biomarker in Glioblastoma by Comprehensive Analysis
por: Ye, Tao, et al.
Publicado: (2021)

26A. An Integrative, Evidence-based Algorithm for Spine-related Pain Disorders
por: Russell, Robb, et al.
Publicado: (2013)

α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway
por: Zhao, Y, et al.
Publicado: (2017)

Novel Natural Inhibitors of CYP1A2 Identified by in Silico and in Vitro Screening
por: Zhu, Ruixin, et al.
Publicado: (2011)

An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer
por: Yang, Zhi-Qiang, et al.
Publicado: (2020)

Polymorphism in the Retinoic Acid Metabolizing Enzyme CYP26B1 and the Development of Crohn’s Disease
por: Fransén, Karin, et al.
Publicado: (2013)

Divergent Roles of CYP26B1 and Endogenous Retinoic Acid in Mouse Fetal Gonads
por: Bellutti, Laura, et al.
Publicado: (2019)

Mandibulofacial Dysostosis Attributed to a Recessive Mutation of CYP26C1 in Hereford Cattle
por: Sieck, Renae L., et al.
Publicado: (2020)

Association of CYP26C1 Promoter Hypomethylation with Small Vessel Occlusion in Korean Subjects
por: Lee, Eun-Ji, et al.
Publicado: (2021)

A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma
por: Lin, Zhu, et al.
Publicado: (2023)

Identification of ZNF26 as a Prognostic Biomarker in Colorectal Cancer by an Integrated Bioinformatic Analysis
por: Liu, Jiaxin, et al.
Publicado: (2021)

xCyp26c Induced by Inhibition of BMP Signaling Is Involved in Anterior-Posterior Neural Patterning of Xenopus laevis
por: Yu, Saet-Byeol, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d00th4q4cn0e8v6ahme1ug8rnm